Tryptamine Therapeutics Limited (‘Tryp’ or the ‘Company’) (ASX: TYP), a clinical-stage biotechnology company focused on the development of an innovative and scalable intravenous-infused psilocin formulation which may be used in conjunction with psychotherapy to address significant unmet medical needs, is pleased to advise that it has successfully and safely completed…
In the tech space this week, two financial institutions applied to offer exchange-traded funds (ETFs) tied to the spot…
CleanTech Lithium PLC (AIM:CTL, Frankfurt:T2N, OTCQX:CTLHF), an exploration and development company advancing lithium projects in Chile, is pleased to…
Antilles Gold Limited (“Antilles Gold” or the “Company”) (ASX: AAU, OTCQB: ANTMF) is pleased to advise that on 28…
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas…
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of…
(TheNewswire) Vancouver, BC, June 28, 2024 TheNewswire Silver North Resources Ltd. (TSX-V: SNAG, OTCQB: TARSF) ‘ Silver North ‘…
Freegold Ventures Limited (TSX: FVL) (Frankfurt: FR4N) (‘Freegold’, the Company) today announced that all matters set out in the…
(TheNewswire) Vancouver, BC June 28, 2024 TheNewswire Coniagas Battery Metals Inc. (TSXV: COS) announces that it will effect a…